BECHER CHARLES enters DNA X, INC. with 108.23K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/8/2023ACC: 0001493152-23-015834
Officer· Chief Sales & Marketing
Since May 2019
108.23K
Baseline shares
100% direct
108.23K
Direct ownership
1 position
400K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned108.23K
Total
108.23K direct108.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 108.23K | Direct |
| Total | 108.23K | 108.23K direct |
Derivative Holdings1
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
400K
Shares owned
N/A
Exercise price
0.419
Expiration
—
Exercise window
—
Total
Underlying
400K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 0.419 | — | — | 400K | N/A |
| Total | 400K | 0.00 | ||||